Dreger, P., Fenske, T. S., Montoto, S., Pasquini, M. C., Sureda, A., & Hamadani, M. (2020). Cellular immunotherapy for refractory DLBCL in the CART era: Still a role for allogeneic transplantation? Biol Blood Marrow Transplant.
Čikaški stil citiranjaDreger, Peter, Timothy S. Fenske, Silvia Montoto, Marcelo C. Pasquini, Anna Sureda, i Mehdi Hamadani. "Cellular Immunotherapy for Refractory DLBCL in the CART Era: Still a Role for Allogeneic Transplantation?" Biol Blood Marrow Transplant 2020.
MLA način citiranjaDreger, Peter, et al. "Cellular Immunotherapy for Refractory DLBCL in the CART Era: Still a Role for Allogeneic Transplantation?" Biol Blood Marrow Transplant 2020.
Upozorenje: Ovi citati možda nisu uvijek 100% točni.